The theme: "Discover Science. Treat Cancer. Change Lives."
This hybrid meeting (virtual or on-site), hosted by Korean Society of Medical Oncology, will feature lectures and real-time Q&A by international speakers with on-site lectures by Korean speakers.
Format: Plenary lectures (Overcoming resistance to checkpoint blockade immunotherapy; Sharing experiences and establishment of guidelines of cancer care in COVID-19 pandemic), special lectures, scientific symposia (Immunotherapy beyond anti-PD1/PDL1 antibody; Resistance mechanism of immunotherapy; Clinical application of ctDNA profile; Targeting endocrine pathway: Breast & Prostate; Recent advances in Stomach cancer & GIST; Recent advances in NSCLC & SCLC), ASCO/KSMO Joint Symposium (Integrating next-generation sequencing into clinical practices: Sharing the real-world experiences), JSMO/KSMO Joint Symposium (Biomarker driven clinical trials: Sharing experiences), ESMO/KSMO Joint Symposium (Updates of IO Treatments and Asian subgroup analysis in oncology clinical trials), luncheon/satellite symposia and poster presentations.
~ 1,700 participants
Venue: Seoul Dragon City
September 2-3, 2021
Seoul, South Korea